Cell-free human immunodeficiency virus type I (HIV-1) virions are believed to affect intra- and inter-host transmission and in vivo pathogenesis. As such, the full evaluation of the molecular processes within HIV-1 virions may be critical towards the understanding of the natural history of HIV-1- induced disease. Reverse transcriptase catalyzes the synthesis of a proviral DNA intermediate, using the genomic viral RNAs as templates. Traditionally, it was assumed that this process occurred only in a target cell, which was infected by a retrovirus. However, recent data, from our laboratory and others, suggest that variable quantities of viral DNA are carried by HIV-1 virions. In addition, virion-associated HIV-1 DNA synthesis can occur in a simple reaction mixture within intact virions, without detergent permeabilization. This process, driven by deoxyribonucleotide triphosphates (dNTPs), may be entitled """"""""natural endogenous reverse transcription"""""""" (NERT). As such, HIV-1 virions can be considered biochemically-active particles. Our laboratory now proposes to evaluate, in complementary specific aims, the molecular structure and mechanisms involved in producing intravirion HIV-1 DNA, and the relationship of NERT to the in vivo pathogenesis of HIV- 1. 1.) The process of NERT will be explored using polymerase chain reaction (PCR) techniques, direct radiolabelling of de novo synthesis of intravirion DNA, plus modified RNase protection assays and Southern blotting using strand specific probes, and certain modifying enzymes. Mutational analyses of specific viral proteins' effects (Envelope, Vpr, Vif) on NERT, and the interactions of specific inhibitors (i.e., viral protease inhibition) with intravirion DNA synthesis will also be evaluated. Molecular effects of critical polyamines, found in key human physiological fluids, on intravirion reverse transcription will be analyzed. These studies will interrelate with infectivity studies of HIV-1 virions harboring viral DNA, concentrating on non-proliferating primary human cells (i.e., quiescent T-lymphocytes and macrophages). Primary clinical viral isolates and molecular analyses of infectivity will be highlighted. 2.) NERT and intravirion reverse transcripts within differing clinical disease stages, and the effects on vertical and horizontal inter-host transmission of HIV-1, will be analyzed. These studies, evaluated in cross-sectional and longitudinal manners, will also address the levels of dNTPs required to induce NERT in various human physiological fluids, with and without other sexually transmitted diseases (STD). Intravirion DNA synthesis will be studied in blood plasma, seminal fluid, and cervical-vaginal secretions of HIV-1-infected-individuals, including individuals with reverse transcriptase-inhibitor resistant viral strains. Thus, these focused and interrelating experiments will allow precise analyses of the molecular structure and mechanistic relationships during NERT, and determine the effects of intravirion DNA synthesis on HIV-1 pathogenesis in vivo.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI038666-04
Application #
2871532
Study Section
Special Emphasis Panel (ZRG5-ARRA (05))
Program Officer
Plaeger, Susan F
Project Start
1996-02-01
Project End
2000-01-31
Budget Start
1999-02-01
Budget End
2000-01-31
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Thomas Jefferson University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Pomerantz, Roger J (2002) HIV-1 reservoirs. Clin Lab Med 22:651-80, vi
Pomerantz, R J (2001) Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy. Biomed Pharmacother 55:7-15
BouHamdan, M; Strayer, D S; Wei, D et al. (2001) Inhibition of HIV-1 infection by down-regulation of the CXCR4 co-receptor using an intracellular single chain variable fragment against CXCR4. Gene Ther 8:408-18
Pomerantz, R J; Zhang, H (2001) Residual HIV-1 persistence during suppressive HAART. Curr Clin Top Infect Dis 21:1-30
Zhang, H; Dornadula, G; Orenstein, J et al. (2000) Morphologic changes in human immunodeficiency virus type 1 virions secondary to intravirion reverse transcription: evidence indicating that reverse transcription may not take place within the intact viral core. J Hum Virol 3:165-72
BouHamdan, M; Kulkosky, J; Duan, L X et al. (2000) Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies. J Hum Virol 3:15-Jun
Kulkosky, J; BouHamdan, M; Geist, A et al. (1999) A novel Vpr peptide interactor fused to integrase (IN) restores integration activity to IN-defective HIV-1 virions. Virology 255:77-85
BouHamdan, M; Duan, L X; Pomerantz, R J et al. (1999) Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selection. Gene Ther 6:660-6
Dornadula, G; Zhang, H; Shetty, S et al. (1999) HIV-1 virions produced from replicating peripheral blood lymphocytes are more infectious than those from nonproliferating macrophages due to higher levels of intravirion reverse transcripts: implications for pathogenesis and transmission. Virology 253:10-6
Shaheen, F; Sison, A V; McIntosh, L et al. (1999) Analysis of HIV-1 in the cervicovaginal secretions and blood of pregnant and nonpregnant women. J Hum Virol 2:154-66

Showing the most recent 10 out of 18 publications